BNTX BioNTech SE

NEUTRAL Impact: 4/10 6-K
Horizon weeks Filed May 7, 2026 Processed 1mo ago SEC 0001776985-26-000033
Notable filing: 6-K
Latest settled — T+20d
BNTX ▼ -4.91% at T+20d
NEUTRAL call ✗ call lost -4.91% · α vs SPY -8.05% · entry $93.02 → $88.45
Next anchor: T+60d in 8w
Last close $85.50 (close Jun 8) · -8.08% from $93.02 entry
Entry anchored
May 6, 03:59 PM ET
via Databento tick
T+1d
+1.19%
call +1.19% · α +0.36%
$94.13
settled 5w ago
T+5d
-0.85%
call -0.85% · α -2.35%
$92.23
settled 27d ago
T+20d
-4.91%
call -4.91% · α -8.05%
$88.45
settled 5d ago
T+60d
call — · α —
in 8w

Price Chart

Loading chart...

Executive Summary

BioNTech announced a new $1.0 billion ADS repurchase program authorized through May 6, 2027, to be funded from existing cash. The program is designed to enhance capital efficiency and support long-term value creation, but it does not offset the company's declining revenue trend.

Actionable Insight

Monitor future 6-K filings for actual repurchase activity and upcoming quarterly results to assess revenue trends. The repurchase program signals management's confidence but does not change the fundamental picture of declining revenues.

Key Facts

  • Up to $1.0 billion in ADS repurchases authorized.
  • Program expires May 6, 2027.
  • Repurchases will be funded from existing cash.
  • ADSs repurchased will be used to satisfy ordinary course obligations.

Financial Impact

$1.0 billion share repurchase authorization, representing approximately 4.2% of market cap.

share countcash

Risk Factors

  • Repurchase execution depends on market conditions and may not materialize.
  • Program does not address underlying revenue decline from COVID-19 vaccine demand.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
81% bullish (26 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001776985-26-000033
Document: a99120260507_bntxxsbbxenxf.htm0001776985-26-000033
Document: 0001776985-26-000033-index-headers.html0001776985-26-000033
Document: 0001776985-26-000033-index.html0001776985-26-000033
Document: 0001776985-26-000033.txt0001776985-26-000033
16 reports for BNTX
Performance horizon
57% Hit rate 4 of 7 directional calls best @ T+20▲ +25.10%Mar 24, 2026
Filters
Rows
Reports for BNTX — sortable, filterable
Type Now
Jun 8, 2026
1d ago
6-K
NEUTRAL ★ 4/10
$88.08 awaiting T+5awaiting T+5$85.50 (−2.93%)
Jun 1, 2026
8d ago
6-K
BULLISH ★ 6/10
$91.70 $88.08▼ −3.95%▼ −1.20%$85.50 (−6.76%)
May 30, 2026
10d ago
Press Release
BULLISH ★ 7/10
$91.70 $88.08▼ −3.95%▼ −1.20%$85.50 (−6.76%)
May 22, 2026
18d ago
6-K
NEUTRAL ★ 4/10
$92.14 $91.70▼ −0.48%▼ −2.15%$85.50 (−7.21%)
May 22, 2026
18d ago
Press Release
NEUTRAL ★ 5/10
$92.14 $91.70▼ −0.48%▼ −2.14%$85.50 (−7.21%)
May 15, 2026
25d ago
6-K
NEUTRAL ★ 4/10
$88.85 $92.25▲ +3.83%▲ +2.21%$85.50 (−3.77%)
May 7, 2026
4w ago
6-K
NEUTRAL ★ 4/10
$93.02 $92.23▼ −0.85%▼ −2.35%$85.50 (−8.08%)
May 5, 2026
5w ago
6-K
BEARISH ★ 7/10
$95.50 $93.66▲ +1.93%▲ +3.91%$85.50 (+10.47%)
May 5, 2026
5w ago
6-K
MIXED ★ 6/10
$95.50 $93.66▼ −1.93%▼ −3.91%$85.50 (−10.47%)
May 5, 2026
5w ago
Press Release
MIXED ★ 6/10
$95.50 $93.34▼ −2.26%▼ −4.25%$85.50 (−10.47%)
Showing 10 of 16

US Market Status

Market Closed — Opens in 9h

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access